While insulin therapy brings unending frustration, it also shows just how far we’ve come in Type 1 treatment.
The makers of Lantus oust their CEO partly over insulin sales. Will this lead to lower prices for basal insulin?
The Insulin Nation Treatment Roundup for November 2014.
A mother shares her son’s struggles with silent hypoglycemia, and what her family did to combat it.
We explore this issue and the science behind obesity with noted science writer Gary Taubes.
The insulin pen is big in Japan, so why not here? It has a lot to do with cost.
Interviews from people with diabetes who struggle to find the insulin and supplies they need in their countries.
The Insulin Nation Research Roundup for October 2014
A endocrinologist evaluates the potential for Dr. Douglas Melton’s new technique to grow insulin-producing beta cells.
Take a look at how the discoverer of insulin is portrayed on the silver screen.
The Insulin Nation Treatment Roundup for October 2014
News reporter Cristina Frank documents a bad middle-of-the-night bout of hypoglycemia.
A look back at advances in diabetes care from Tes Tape to home insulin pumps.
Tired of paying high prices for Sanofi’s basal insulin? An alternative to Lantus has been blocked from the marketplace.
Laura Kronen shares two memorable lows where she had to put manners aside to raise her blood sugar levels.
The latest Insulin Nation treatment roundup.
A T1D activist and researcher dives into the available research for clues.
The latest Type 1 diabetes tech news.
Read how a fundraising website is helping a 10-year old with Type 1 buy a diabetes service dog.
With new diagnostic tools, doctors can track the insulin production of people with diabetes who are long past the honeymoon period.
Sign up to receive email notifications about new Insulin Nation stories